Business Context and Reporting Period
Pediatrix Medical Group, Inc. filed its Form 10-Q for the quarterly period ended June 30, 1999. The Company operates as a physician group providing neonatal and pediatric services. As of August 9, 1999, there were 15,502,022 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1999 | Six Months Ended June 30, 1998 |
|---|---|---|
| Net Patient Service Revenue | $110,593,000 | $83,952,000 |
| Net Income | $15,062,000 | $13,226,000 |
| Diluted EPS | $0.95 | $0.83 |
| Operating Cash Flow | $9,534,000 | $9,655,000 |
| Working Capital | $28,928,000 | $14,915,000 (Dec 31, 1998) |
| Line of Credit Utilized | $41,893,000 | $7,850,000 (Dec 31, 1998) |
| Total Debt (Line of Credit + Notes) | $44,143,000 | $10,200,000 (Dec 31, 1998) |
Liquidity: The Company had $588,000 in cash and cash equivalents as of June 30, 1999. It maintains a $75 million revolving credit facility with $33.1 million available.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 31.7% year-over-year for the six-month period, driven primarily by the acquisition of eight physician group practices. Same-unit revenue was essentially flat.
- Expense Increases: Salaries and benefits rose 33.7% due to new physician hires and support staff. Supplies and other operating expenses increased 57.7%, attributed to new units, legal fees related to government investigations, and audit fees.
- Acquisition Activity: The Company spent approximately $49.2 million in cash and issued 1,000,000 subsidiary shares for acquisitions in the first six months of 1999.
- Debt Levels: Borrowings on the line of credit increased by $34 million to fund acquisitions, raising total debt significantly compared to the prior year.
Guidance, Risks, and Contingencies
- Legal Proceedings: The Company is facing consolidated federal securities class action lawsuits alleging violations regarding accounting practices (capitalization of acquisition payments) and revenue recognition. Plaintiffs seek undetermined damages.
- Government Investigations: State investigators in Arizona, Colorado, and Florida have requested information or issued subpoenas regarding the Company's billing practices. The Company is cooperating but cannot predict the material impact.
- Accounting Change: Effective January 1, 1999, the Company began expensing incremental internal costs related to acquisitions rather than capitalizing them, resulting in approximately $647,000 in expenses for the six-month period.
- Year 2000 Compliance: The Company expects to complete testing of critical systems by the end of the third quarter of 1999. Estimated costs are not expected to exceed $500,000.
- Subsequent Event: In July 1999, the Company purchased approximately 23.5% of a subsidiary's outstanding shares from minority shareholders for $17.6 million.
Investor Verification Checklist
- Verify the status and potential financial impact of the federal securities class action lawsuits and state billing practice investigations.
- Confirm the sustainability of revenue growth given that same-unit revenue was flat and growth was acquisition-driven.
- Monitor the utilization of the $75 million credit line, which is currently 56% utilized ($41.9 million outstanding).
- Review the impact of the change in accounting policy regarding acquisition costs on future earnings.
- Assess the Company's ability to maintain liquidity given the net decrease in cash and high acquisition spending.